Mucormycosis and COVID-19 (Download PDF)

Doorsteptutor material for CLAT is prepared by world's top subject experts: fully solved questions with step-by-step explanation- practice your way to success.

Mucormycosis and COVID-19

  • Mucormycosis is a serious but rare fungal infection that causes headache, heaviness in the facial area, or swelling. This infection is being widely reported in COVID-19 recovered patients. Mucormycosis is also known as Zygomycosis.
  • Nearly eighteen suspected cases of Mucormycosis were reported in 2011. In December 2020,44 cases have been reported in Ahmedabad with nine deaths and were linked to COVID-19 infections.
Mucormycosis and COVID-19


  • It infects the throat, nasal area and spread to eyes, brain and then the entire body.
  • It proves fatal the time it starts infecting the brain.
  • It can damage immunity thereby making patients infection-prone.
  • It may also result in multiple organ failure.
  • This infection is caused by a group of molds called Mucormycetes.
  • The fungus can enter the human body through:
    • A cut
    • Burn
    • Other types of skin injury
  • Once the fungal spores from air are inhaled, the lungs get affected.
  • The mortality rate of the disease is 50 % .

People at greater risk:

  • Diabetes.
  • Cancer or people who underwent organ transplant.
  • Stem Cell Transplant.


  • If detected at an early-stage, treatment can lead to better outcome.
  • CT scan and endoscopy for diagnosis are done initially.
  • Antifungal injections are given after finding its occurrence.
  • From the affected organs, Surgical interventions may be needed to remove fungal balls.
  • Even post-COVID one should keep going for regular health check-ups.

- Published/Last Modified on: June 5, 2021

Science/Technology, Health

Developed by: